Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
91 studies found for:    "Hepatic encephalopathy"
Show Display Options
Rank Status Study
1 Not yet recruiting Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
Conditions: Hepatic Encephalopathy;   Minimal Hepatic Encephalopathy;   Cirrhosis
Interventions: Procedure: Vastus Muscle Biopsy;   Drug: LOLA or placebo;   Other: Cognitive assessment (PHES);   Other: Cognitive Assessement (Cogstate);   Other: blood and urine sampling;   Other: Nutritional assessment;   Other: MRI brain and spectroscopy;   Other: MRI leg cross section;   Other: Functional MRI (working memory and attention tasks)
2 Recruiting Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Conditions: Acute Episode of Overt Hepatic Encephalopathy;   Hepatic Encephalopathy
Interventions: Drug: ornithine phenylacetate;   Drug: placebo intravenous infusion
3 Recruiting Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Conditions: Hepatic Encephalopathy;   HE;   Cirrhosis;   Altered Mental Status;   AMS
Interventions: Drug: Lactulose;   Drug: Polyethylene Glycol 3350
4 Unknown  The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hepatitis C;   Liver Cirrhosis
Intervention: Drug: Rifaximin (drug)
5 Completed Cerebrovascular Reactivity in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention:
6 Unknown  RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin alone, Rifaximin combined with Lactulose
7 Completed Neuromonitoring of Hepatic Encephalopathy
Conditions: Liver Failure, Acute;   Hepatic Encephalopathy
Intervention: Device: Molecular Adsorbent Recirculating System (MARS)
8 Withdrawn Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
9 Not yet recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
10 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
11 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
12 Unknown  Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
Conditions: Hepatocerebral Encephalopathy;   Portal-Systemic Encephalopathy;   Encephalopathy, Hepatic;   Encephalopathy, Hepatocerebral
Interventions: Drug: Lactulose;   Drug: Placebo
13 Completed Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Condition: Hepatic Encephalopathy
Interventions: Drug: VSL#3;   Other: Placebo
14 Completed Rifaximin in Minimal Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Rifaximin;   Drug: placebo
15 Completed AST-120 Used to Treat Mild Hepatic Encephalopathy
Condition: Mild Hepatic Encephalopathy
Intervention: Drug: AST-120
16 Recruiting The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
17 Unknown  Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hypertension, Portal;   Liver Cirrhosis
Interventions: Drug: Erythromycin;   Drug: Neomycin
18 Completed Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Dietary Supplement: Branched-chain amino acids;   Dietary Supplement: Maltodextrin
19 Unknown  Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate and lactulose;   Drug: placebo and lactulose
20 Recruiting Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Conditions: Refractory Ascites;   Hepatic Hydrothorax;   Hepatic Encephalopathy;   Cirrhosis
Interventions: Other: Oral glutamine challenge;   Other: Psychometric Tests

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years